NeoStem Inc.

Adult stem cell therapeutics

Based in Agoura Hills, Calif., NeoStem Inc. is pioneering the pre-disease collection, processing and storage of adult stem cells for future medical treatments. NeoStem was founded by former executives and founders of StemCyte, Inc., the world’s second largest umbilical cord stem cell bank. Phase III Medical, Inc. (OTCBB:PHSM), acquired NeoStem, Inc. in January 2006.

Robin Smith, M.D., MBA, CEO
Mark Weinreb, President
Larry A. May, CFO
Denis O. Rodgerson, PhD, Director of Stem Cell Science

Ron Rothenberg, M.D.
Douglas Wynyard
Richard Gatti, M.D.
Neil C. Livingstone, Dr.

Wayne A. Marasco, M.D., Ph.D.
Douglas W. Losordo, M.D.
Stephen D. Nimer, M.D.

420 Lexington Avenue
Suite 450
New York, NY 10170
USA
Phone: +1-212-584-4180
Fax: +1-212-656-1933

NeoStem is engaged in autologous stem cell collection for therapy, which does not involve embryonic or foetal stem cells in any way. The first service NeoStem offers is autologous stem cell banking. The stem cells are preserved in cryostorage as such these cells are in suspended animation and chemical and biologic reactions cease. The NeoStem collection centre is located at the Good Samaritan Medical Office building in Los Angeles.
The company has developed and filed numerous patents on the processing techniques and therapeutic applications of adult stem cells for future health care needs.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.